In a multicenter population-based case-control study that included 1,588 cases and 1,394 controls less than age 45 years, the authors examined the relation of adult body size and breast cancer risk among young women. Breast cancer patients and healthy controls were identified in Atlanta, Georgia; Seattle/Puget Sound, Washington; and central New Jersey. Cases were newly diagnosed with in situ or invasive breast cancer during the period of May 1, 1990, through December 31, 1992. Anthropometric variables thought to reflect early environmental factors (e.g., height, sitting height, frame size), obesity, and body fat distribution were measured directly. Height, but not sitting height or frame size, was a breast cancer risk factor. Risk of the disease was increased 46 percent among women in the fourth quartile of height (>167 cm) compared with women in the first quartile (<159 cm). Body weight, but not body fat distribution, was related to breast cancer risk. Risk of the disease was 35 percent lower among women in the highest quartile of Quetelet index (>28.8 kg/m 2 ) compared with women in the lowest quartile (<22.0 kg/m 2 ). Risk of the disease was increased about 2.1-fold (95 percent confidence interval 1.2-3.8) among women who were thin and tall compared with women who were heavy and short. Thus, breast cancer risk was increased substantially among younger women with a linear body type. Am J Epidemiol 1996; 143:698-706.
In etiologic studies of breast cancer, anthropometric measurements may serve as useful biologic markers of environmental factors, including contemporary and past diets. In recent years, height has reemerged as a breast cancer risk factor (1) . Frame size, another index of skeletal dimension, has also been associated with breast cancer risk (2, 3) . As hypothesized by others (4, 5) , height may be related to mammary gland mass and, by inference, to the niimber of ductal stem cells at risk of transformation. Ecologic studies suggest an association of both height and breast size with breast cancer incidence (5) . Adult stature may reflect early environmental influences such as energy intake during child-hood and adolescence. Sitting height may be particularly sensitive to early diet, and relative sitting height (i.e., the sitting height-to-standing height ratio) has been proposed as an indirect index of preadolescent nutrition. Briefly, long-waisted women tend to experience early menarche, and early maturation may reflect increased nutrition (i.e., excess energy intake) during childhood (6) .
The relation of obesity to breast cancer risk has been considered in numerous studies. For many years, obesity was widely regarded as a risk factor for breast cancer. More recently, excess weight has been viewed as a relatively modest risk factor (7) . Furthermore, risk associated with obesity is, in most studies, limited to older postmenopausal women. In younger women (e.g., those younger than age 45 years), obesity appears to be inversely related to risk of the disease. Initially, the apparent protective effect of obesity in younger women was attributed in large part to detection bias (8, 9) . Later studies indicated that the inverse association was not adequately explained by difficulties in detection of tumors in heavy women (10, 11) . The protective effect of excess weight may be related to hormonal changes associated with obesity (e.g., reduced exposure to progesterone) (12) . Studies comprised mainly of postmenopausal women (13) (14) (15) (16) show a direct relation of upper-body or central adipos-ity and breast cancer risk independent of generalized obesity. To our knowledge, there is only one report of the relation of body fat distribution and breast cancer risk among premenopausal women (16) .
Few studies of body size and breast cancer risk have included large numbers of women diagnosed at a young age. Furthermore, most studies of younger women have been limited to the assessment of height and weight. To assess fully the relation between body size and breast cancer risk among young women, we undertook a case-control study that included a variety of anthropometric measurements.
MATERIALS AND METHODS
This population-based case-control study (17) was conducted in three geographic areas covered by cancer registries: the metropolitan areas of Atlanta, Georgia; Seattle/Puget Sound, Washington; and five counties in central New Jersey. The present analysis is based on women aged 20-44 years who were newly diagnosed with in situ or invasive breast cancer during the period May 1, 1990, through December 31, 1992. Hospital records of eligible patients were abstracted to document details on the clinical and pathologic characteristics of the diagnosed breast cancers. Controls were frequency matched by geographic area and age to the expected distribution of cases and were identified through random digit dialing (18) . A 90.5 percent response rate to the telephone screener was obtained from 16,254 telephone numbers assessed as residential.
Interviews were obtained from 1,669 of the 1,940 eligible cases (86.0 percent) and 1,505 of the 1,912 eligible controls (78.7 percent). The major reasons for noninterview were subject refusals (6.6 percent of the cases and 12.9 percent of the controls) and physician refusals (5.8 percent of the cases). Among the controls, the overall response rate was 71.2 percent (telephone screener rate times the interview response rate). Structured in-person interviews, which lasted a median time of 71 minutes, collected detailed information regarding demographic factors; reproductive and menstrual history; contraceptive behavior; use of exogenous hormones; medical and screening history; adolescent diet; alcohol consumption; physical activity; smoking; occupation; family history of cancer, and certain lifestyle factors and opinions about cancer causation. In addition, participants were asked, either at the time of the personal interview or subsequently, to complete a 100-item dietary questionnaire.
Interviewers at each of the three centers received standardized training in anthropometric techniques. At least twice during the course of the study, the anthropometry instructor evaluated the quality of the data collected at each study center. Accuracy and reliability of the measurements were determined by having the anthropometry instructor and interviewers perform repeated measurements on volunteer subjects. Measurements of the interviewers were compared with those of the instructor, and problems were corrected on site. Measuring equipment was standardized regularly throughout the study. As expected, some measurements were more reliable than others. For example, accuracy and reliability were greatest for height and weight and least for the skinfold determinations.
The following anthropometric measurements were made: standing and sitting height were measured to the nearest 0.1 cm with a custom-made stadiometer using a height-measuring rod (Seca Corp., Columbia Maryland); elbow and wrist widths to the nearest 0.1 cm with a caliper (Holtain bicondylar vernier caliper, Holtain Ltd., Seritex Inc., Carlstadt, New Jersey); weight to the nearest 0.2 kg with a portable digital scale (Integra 815, Seca Corp., Columbia Maryland); waist and hip circumferences to the nearest 0.1 cm with a flexible measuring tape (Lufkin steel measuring tape, Seritex, Inc., Carlstadt, New Jersey); mid-upper arm circumference to the nearest 0.1 cm with a nonstretch plastic tape (insertion circumference tape, Ross Laboratories, Columbus Ohio); and subscapular and triceps skinfolds to the nearest 0.2 mm with skinfold calipers (Holtain Tanner-Whitehouse skinfold caliper, Holtain Ltd., Seritex, Inc., Carlstadt, New Jersey). Mid-upper arm circumference was measured at the midpoint of the arm between the acromion and olecranon processes. Waist circumference was measured just superior to the iliac crest of the pelvis; the measurement site was often at the level of the umbilicus. Hip circumference was measured to include the maximum extension of the buttocks and usually included underclothing plus a light loose-fitting garment. Triceps skinfolds were measured on the posterior midline of the arm at the same level as the mid-upper arm circumference. The subscapular skinfold site was identified by locating the area just below the inferior angle of the scapula. Skinfolds, mid-upper arm circumference, and elbow and wrist widths were measured on the right side of the body unless the subject reported surgery of the right breast or any past or present injury to the right arm that resulted in pain, swelling, or deformity. Because of concerns that treatment might affect measurements, cases were asked if they had received radiation therapy, chemotherapy, or any other drug therapy since their surgery. Cases were identified through rapid ascertainment systems, and 84 percent of cases were interviewed and measured within 6 months of diagnosis.
With the exception of height, sitting height, and weight, measurements were taken twice, and a third measurement was made if the difference of the first two measurements exceeded a predetermined limit. Obvious outliers were removed before the means of all replicates were calculated. Sixty cases and 111 controls provided either no anthropometry information or so few measurements that neither body mass index nor body fat distribution could be calculated (seven of these cases and 48 controls were excluded because they were pregnant or less than 7 months postpartum). Because controls were identified through telephone sampling, 21 cases without residential telephones were eliminated from the analysis. This analysis focused on 1,588 cases and 1,394 controls.
To assess obesity, we evaluated measured weight, the more commonly reported Quetelet body mass index (kg/m 2 ), and a body mass index for women (kg/m 15 ) recommended by the National Center of Health Statistics (19) . The three variables were highly correlated and similarly related to breast cancer risk; only Quetelet index and measured weight are reported. To assess fat distribution patterns, two indices were derived. The waist-to-hip circumference ratio was used as an index of upper-body or android obesity (20) . The subscapular-to-triceps skinfold ratio provided an index of central obesity (21), a measure of subcutaneous fat on the trunk of the body versus the periphery.
Logistic regression was used to obtain relative risk estimates (odds ratios) and their 95 percent confidence intervals (22) . Multivariate logistic regression was used to adjust for potential confounders and to test the statistical significance of interaction terms. In analyses involving stage of diagnosis as an outcome, we used polychotomous logistic regression to compare each case group simultaneously with the controls (23) . Tests for trend in the logistic analyses were obtained by categorizing the exposure variable and treating the scored variables as continuous after eliminating unknown values.
RESULTS
The median age of both cases and controls was 40 years. The two groups did not differ by race, with 80 percent being white, 15 percent black, and 5 percent other races. The major risk factors for breast cancer were a family history of breast cancer, a previous breast biopsy, limited number of births, a late age at first birth, and alcohol consumption (table 1). Disease risk was lower among postmenopausal compared with premenopausal women. Early age at menarche and oral contraceptive use were relatively weak risk factors. Cigarette smoking and education were not related to risk of the disease. Potential risk factors were included in the multivariate analyses if they were related to disease risk and were clearly associated with any of the anthropometry variables. In addition to age and study site as matching variables, we included race, age at menarche, oral contraceptive use, parity, and alco-hoi consumption as potential confounders. Addition of other variables (e.g., family history, smoking, and education) did not materially alter the risk estimates. Age was modeled as a continuous variable, but results were similar when it was included as a categorical variable.
Skeletal dimensions
Height and one measure of frame size were associated with risk (table 2) . Height was directly related to breast cancer risk. Women taller than 167 cm had a 46 percent greater risk compared with women less than 159 cm tall. While a high sitting-to-standing height ratio was associated with early onset of menarche (data not shown), breast cancer risk was reduced somewhat among long-waisted women (p for trend = 0.08). Elbow width was not a breast cancer risk factor. However large frame size, as assessed by wrist width, was protective. Risk was 22 percent lower among women in the fourth quartile of wrist width (>5.3 cm) compared with women in the lowest category (<4.9 cm).
Weight, adiposity, and body fat distribution
Weight and adiposity, but not body fat distribution, were related to breast cancer risk ( 
After adjustment for weight, neither waist nor hip circumference was related to risk of breast cancer (data not shown). A predominance of upper body fat, as measured by the waist-to-hip circumference ratio, was not associated with risk. Triceps skinfold thickness was not related to breast cancer risk (data not shown), but subscapular skinfold thickness was in- . The subscapular-to-triceps skinfold ratio, an indicator of central versus peripheral obesity, showed no relation to disease risk. We explored the possibility mat the relation of body fat distribution to breast cancer risk might be modified by other anthropometric variables or risk factors. We did not identify any subgroups, including levels of weight, Quetelet index, or family history of breast cancer, in which a predominance of upper-body fat or central adiposity significantly affected breast cancer risk.
For each anthropometry variable, we examined the risk relation by strata of breast cancer risk factors shown in table 1. The effects of height were remarkably consistent across strata of other risk factors. The associations of weight and Quetelet index to breast cancer risk were more variable, but there was no clear evidence of effect modification by other risk factors. The inverse associations of wrist width and subscapular skinfold thickness with risk were clearly limited to nulliparous women. Relative risks of breast cancer across increasing quartiles of wrist width were 0.7, 0.6, and 0.4 (p for trend = 0.0016). The risk estimates for increasing quartiles of subscapular skinfold thickness were 0.7, 0.5, and 0.3 (p for trend = 0.0003). Among parous women, the estimates for increasing quartiles of wrist width were 0.9, 0.8, and 0.9. The corresponding values for subscapular skinfold thickness were 1.1, 1.1, and 1.0.
Height, weight, and breast size
In other analyses, we focused on effects of breast size, height, and weight. Among controls, we cross-classified height and weight quartiles with bra cup size (A, B, C, D). Height was somewhat related to breast size. For example, cup size A was reported by 17.2 percent of controls and became less common across increasing quartiles of height (19.8, 18.3, 16 .0, and 15.8 percent). Weight was clearly related to bra size (Spearman r = 0.37, p = 0.0001). The distribution of cup size A across increasing quartiles of weight was 34.4, 20.5, 11.3, and 3.8 percent. After adjustment for height, weight, and other potential confounders, the risk estimates for increasing levels of bra cup size were 1.1, 1.0, and 1.2 (p for trend = 0.37). When the analysis was stratified by two categories of body mass index (lower and upper quartiles of Quetelet index), a pronounced association of breast size and risk was observed in thin women (table 4) , with bra cup size D being associated with a twofold increased risk compared with thin women with cup size A. Bra size was not a risk factor among heavier women.
Adiposity and the menstrual cycle
We explored the possibility that the protective effect of excess weight was related to its association with menstrual factors (e.g., onset and regularity of menses). The reduced breast cancer risk associated with greater weight could not be explained by age at menarche because the heavier women had an earlier age at menarche, which was associated with increased risk. The women were asked when after menarche their periods became "regular or predictable." Women who reported that they could never predict when their menstrual period would start were classified as having irregular cycles. Irregularity was used as a crude indicator of anovulatory cycles. Risk of breast cancer was 34 percent lower (95 percent CI 0.5-0.8) among women whose menstrual cycles never became regular compared with women who reported regular menstrual cycles. While controls with irregular menstrual cycles were heavier than controls who were regular, both adiposity and regularity of menstrual cycles predicted breast cancer risk (table 5) .
Detection bias
We examined the issue of detection bias. Thirty-six percent of cases were diagnosed with regional or distant tumors. The percentage of advanced tumors was higher for women in the highest quartile of Quetelet index compared with women in the lowest quartile (41 versus 31 percent). If tumors are more difficult to detect in obese women, then one would expect the protective effect of excess weight to be restricted to small tumors. The inverse association of excess weight and risk was, in fact, limited to in situ and local tumors and was most pronounced among women with in situ cancers (table 6). Next, we examined the risk relation by the three main detection methods_(mammography, routine self-examination, and accidental discovery by the woman or her partner). This approach suggested that the protective effect of excess weight could not be attributed entirely to detection bias. One would expect that obesity could not mask the disease if a relatively sensitive method such as mammography were used to detect tumors. Among women with in situ and local cancers, the inverse association persisted when the disease was detected by the most sensitive of the three methods, mammography.
To evaluate the possibility of selection bias, we compared the height and body mass index (kg/m 2 ) of a subgroup of eligible cases and controls who were classified as nonrespondents. After physician refusals were excluded, subjects who could not be interviewed personally were contacted and asked to participate in a 5-minute telephone or mailed interview that included questions about current height and weight 1 year previously. A total of 34 cases and 122 controls agreed to participate. Among the "nonrespondents," cases were taller than controls (164. • Relative risks (RR) and 95% confidence Intervals (Cl) adjusted for age, study site, race, menarche, oral contraceptive use, parity, alcohol consumption, and height For some variables, the number of observations does not equal 2,982 (1,588 cases and 1,394 controls) because of missing values. 
DISCUSSION
It is unclear why height should emerge repeatedly as a predictor of breast cancer, particularly in relatively affluent population groups (9, 16, (24) (25) (26) (27) (28) unlikely to have been exposed to energy-restricted diets during critical growth periods. In this study, the association was not explained by potential confounders such as alcohol consumption, oral contraceptive use, parity, or education. Ballard-Barbash (29) proposed that genetic and environmental factors, including diet, may influence the hormones that regulate epiphysial closure and thus attained height. Presumably, these hormones or perhaps certain endocrine profiles also would be related to subsequent risk of breast cancer. Other investigators have hypothesized that adult height may be related to mammary density or mammary gland size, which, in turn, may be related to breast cancer risk (4). In our investigation, the increased risk associated with height did not reflect effects of mammary gland size as estimated by bra size. It is possible, however, that bra size is an inadequate proxy for mammary gland mass except at the very low range of its distribution.
We observed a direct relation of breast size and breast cancer risk in thin women. Breast size, as estimated by bra cup size, is not an accepted risk factor for breast cancer. In fact, the majority of analytic epidemiologic studies show no association (5) . The breast is comprised mainly of adipose tissue and using bra cup size as a proxy for mammary gland size undoubtedly results in considerable misclassification. Perhaps mis-classification is reduced when the analysis is restricted to thin women. Interestingly, one of the few casecontrol studies to show a positive association of breast size and risk was of Japanese women (30) .
Increased sitting height has been proposed as an index of early maturity and may reflect nutrition during childhood (6) . Long-waisted women in our study did experience early menarche, but increased relative sitting height was not related to increased disease risk. In fact, the relative sitting height of cases was slightly less than that of controls. A similar observation was made in two previous studies (2, 3) . If relative sitting height is associated with decreased risk of breast cancer, then the other component of height (i.e., total height minus sitting height) must be associated with slightly increased risk. Perhaps, in future studies, attention should be focused on leg length rather than sitting height.
In contrast to two previous studies comprised mainly of postmenopausal women (2, 3), frame size was not directly related to risk of breast cancer in our study population of younger women. We cannot explain the observation of an inverse association between wrist width and disease risk or why the association was limited to nulliparous women.
In agreement with numerous studies conducted in high-risk countries (8, 10, (31) (32) (33) (34) (35) , we observed that the risk of breast cancer among young women was lower among heavy compared with lean women. We also noted a dramatic reduction in risk among a small number of extremely heavy women (>110 kg). The effects of marked obesity should be explored in future studies. To the extent that our assessment of menstrual regularity (i.e., ever vs. never) reflected ovulation (36) , the protective effect of excess weight could not be explained by increased frequency of anovulatory cycles. Previous reports (10, 11) and this study indicate that the protective effect of excess weight is not fully explained by detection bias. One argument against detection bias is provided in a report by Pathak and Whittemore (35) , who examined the incidence of breast cancer in high-, medium-, and low-risk countries. Breast cancer incidence was inversely associated with body mass index among women in high-risk countries and directly associated with risk in mediumand low-risk populations. As noted by the authors, it seems unlikely that obesity would mask detection of disease in high-risk but not in medium-risk countries because controls in both populations had similar distributions of body mass index.
It is unlikely that the inverse association between weight and breast cancer risk was due to disease effects. The relation was least pronounced in women with more advanced disease. Furthermore, the inverse association of weight and breast cancer risk has been seen in prospective studies with extended follow-up (26, 27) . It is not likely that the lower weight of cases compared with controls was due to treatment effects since weight gain rather than loss is a reported side effect of adjuvant chemotherapy (37) . If this were the case, we would have underestimated the protective effect of excess weight. We considered the possibility that treatment effects might explain why we did not observe an inverse association of weight and risk among women with regional/distant disease. Ninety percent of these women received chemotherapy prior to the interview compared with 54 percent of women with local disease and less than 1 percent of women with in situ cancer. Cases were asked to recall their weight 1 year prior to the interview. The difference between recalled weight and interview weight indicated that women with regional/distant disease did not gain more weight during the interval compared with women with less advanced breast cancer (in situ, 2.4 kg; local, 2.3 kg; regional distant, 1.9 kg).
Similar to our results, waist-to-hip ratio was not associated with risk of breast cancer in premenopausal women in a study by Bruning et al. (16) , even though a predominance of upper body fat has been associated with a biochemical profile (e.g., decreased sex hormone-binding globulin, increased bioavailable estradiol, hypertriglyceridemia) thought to increase disease risk (16, 38) . Sellers et al. (39) observed that upper-body obesity was associated with risk among postmenopausal women with a family history of breast cancer. In our study, family history did not act as an effect modifier.
In summary, we observed a positive association between adult height and breast cancer risk among women with early-onset disease. In agreement with other reports, it appears that adult height can be a risk factor in a population unlikely to have experienced caloric or other nutrient restriction during critical growth periods. We could only crudely assess the relation of height, mammary gland size, and risk of breast cancer, but the height effect could not be explained by an association with bra size. The risk estimates associated with the combined effects of tallness and thinness suggest that surface area and metabolic rate may be important. While weight data obtained after diagnosis must be interpreted cautiously, our study provides further evidence that breast cancer risk is lower among heavy compared with thin women with early-onset disease. The protective effect of excess weight was not adequately explained by detection bias and did not appear to be related either to disease or to treatment effects. Young obese women may have a reduced risk of breast cancer because they have more anovulatory cycles and thus lower exposure to estrogen and progesterone. Our results did not support this hypothesis, but our method of assessing regularity of ovulation was imprecise. Body fat distribution was not associated with risk of breast cancer in young women. This observation was unexpected given that upperbody obesity is associated with a hormonal profile thought to increase breast cancer risk. As is the case with generalized obesity, body fat distribution also appears to have a different effect in younger versus older women. To date, there are no established biologic explanations for these age-related differences.
